SI050021: Elbasvir-d6 label-new enabling enzymatic extension to sialylated

enabling enzymatic extension to sialylated and fucosylated structures such as sialyl-LacNAc and Lewis antigens

Fmoc-Thr[β-D-Gal(Ac)4-(1-3)-α-D-GalNAc(Ac)2]-OH

C20H30N4NaO16P / 636

Triantennary β-D-GalNAc pentaethyleneglycol (PEG5) carboxylic acid ligand

4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1

SI050021: Elbasvir-d6 label-new enabling enzymatic extension to sialylatedC49H49D6N9O7 888. 05 HIV Infection Elbasvir d6 Trideuteriomethyl N [(2S) 3 methyl 1 [(2S) 2 [5 [(6S) 3 [2 [(2S) 1 [(2S) 3 methyl 2 (trideuteriomethoxycarbonylamino)butanoyl]pyrrolidin 2 yl] 1H imidazol 5 yl] 6 phenyl 6H indolo[1,2 c][1,3]benzoxazin 10 yl] 1H imidazol 2 yl]pyrrolidin 1 yl] 1 oxobutan 2 yl]carbamate